chr20-38132492-C-T
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004613.4(TGM2):c.1624G>A(p.Val542Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000119 in 1,613,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V542F) has been classified as Benign.
Frequency
Consequence
NM_004613.4 missense
Scores
Clinical Significance
Conservation
Publications
- type 2 diabetes mellitusInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152140Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000123 AC: 31AN: 251470 AF XY: 0.000147 show subpopulations
GnomAD4 exome AF: 0.000120 AC: 176AN: 1461852Hom.: 0 Cov.: 32 AF XY: 0.000116 AC XY: 84AN XY: 727226 show subpopulations
GnomAD4 genome AF: 0.000105 AC: 16AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74316 show subpopulations
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at